Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Quinethazone, marketed as Hydromox, is a thiazide diuretic indicated for hypertension. Patients may experience adverse reactions such as dizziness, dry mouth, nausea, and hypokalemia.
- Mechanism
- Curator reviewed
As a diuretic, quinethazone inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like quinethazone also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of quinethazone is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle.
- Primary indication
- Used to treat hypertension.Curator reviewed
- Formula / weight
- C10H12ClN3O3S · 289.739 g/mol (avg)
- Also known as
- Quinethazon
- Code names
- CL 36010
Resolves to
AGMMTXLNIQSRCG-UHFFFAOYSA-NSMILESCCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=OWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Quinethazone, and which of those have an active Phase 3 trial?